An innovative herbal product for the prevention of osteoporosis

Chinese Journal of Integrative Medicine

Volumn 17, Issue 10, 2011, Pages 744-749

  Leung, Ping Chung ^a   Cheng, King Fai ^a   Chan, Yat Heung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone mineral density; Herbal product; Prevention of osteoporosis

Indexed keywords

BO GU LING; CHINESE DRUG; HERBACEOUS AGENT; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACKACHE; BONE DENSITY; COMMON COLD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HIP; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSE; MULTICENTER STUDY; OSTEOPENIA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TIBIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; MIDDLE AGED; OSTEOPOROSIS; PATHOPHYSIOLOGY; QUESTIONNAIRE; RADIOGRAPHY;

BONE DENSITY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858307559     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0876-y     Document Type: Article

References (21)

1. Riggs BL, Mel ton LJ. The wor ldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17(5 Suppl):S505-S511.
2. Dambacher MA, Schmitt S, Schacht E, Ito M, Neff M, Muller R, et al. Bone structures in vitro and in vivo in animals and men: a view into the future. J Miner Stoffwechs 2004;2:22-28.
3. National Institutes of Health (NIH), USA (2000). NIH consensus statement on osteoporosis prevention, diagnosis and therapy. 27-29 March 2000. Accessed at http://consensus.nih.gov.
4. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-650.
5. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008;22:346-350.
6. Leung F, Lau TW, To M, Luk KDK, Kung AWC. Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates. BMJ Case Rep 2009;368:316-320.
7. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294-1301.
8. Yang F, Xu MR, Yang MF, Lam CH, Lau MT, Yuan ZH. Patterns of the use of traditional Chinese medicines in the treatment of osteoporosis. Chin J Clin Rehabil (Chin) 2005;9:203-205.
9. National Committee of Pharmacopoeia. Pharmacopoeia of the People's Republic of China (2005). Part I. Kidney tonics Chinese pharmacopoeia. Beijing: Chemical Industriy Press; 2005:444-445.
10. Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS. Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 2006;29:291-296.
11. Sun Y, Lee SMY, Wong YM, Lau CP, Shaw PC, Qin L, et al. Dosing effects of an antiosteoporosis herbal formula - a preclinical investigation using a rat model. Phytotherapy Res 2008;22:267-73.
12. Xie YM, Zhu YY, Wu TX. Effects and safety of traditional Chinese medicine for treating postmenopausal osteoporosis: a systematic review. Chin J Evid Based Med (Chin) 2005;5:29-41,74.
13. Leung PC. Intelligent use of traditional Chinese medicine. In: a comprehensive guide to Chinese medicine. Chapter 1. Singapore: World Scientific Publisher; 2003:1-18.
14. Chen ST, Dou JH, Temple R, Agarwal R, Wu KM, Walker S. New therapies from old medicine. Nat Biotechnol 2008;26:1077-1083.
15. Wong SY, Kwok T, Woo J, Lynn H, Griffith JF, Leung PC. Bone mineral density and the risk of peripheral arterial disease in men and women: results from Mr. and Ms. Os, Hong Kong. Osteoporos Int 2005;16:1933-1938.
16. Yu S, Chen K, Li S, Zhang K. In vitro and in vivo studies of the effect of a Chinese herb medicine on osteoclastic bone resorption. Chin J Dent Res (Chin) 1999;2:7-11.
17. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
18. Kerr D, Morton A, Dick I, Prince R. Exercise effects on bone mass in postmenopausal women are site-specific and loaddependent. J Bone Mineral Res 1996;11:218-225.
19. Chau FT, Chan HY, Cheung CY, Cheng JX, Liang YZ, Kvalhe OM. Recipe for uncovering the bioactive component sinherbal medicine. Anal Chem 2009;81:7217-7225.
20. Chau FT, Liang YZ, Gao JB, Zhao S. Chemometrics: from basic to wavelet transform. Vol. 164. Chemical Analysis Series. Hoboken: John Wiley and Sons, Inc; 2004:232-249.
21. Mok DK, Chan FT. Chemical information of Chinese medicine: a challenge to chemist. Chemom Intell Lab Syst 2006;82:210-217.